Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.
about
Biodegradable poly(ester urethane)urea elastomers with variable amino content for subsequent functionalization with phosphorylcholine.Free electron laser induces specific immobilization of heparin on polysulfone films.Surface characteristics and biocompatibility of lactide-based poly(ethylene glycol) scaffolds for tissue engineering.A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects.The behavior of ROS-scavenging nanoparticles in blood.Toward new biomaterials.The influence of thrombus components in mediating bacterial adhesion to biomaterials.Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.Fabrication and anti-fouling properties of photochemically and thermally immobilized poly(ethylene oxide) and low molecular weight poly(ethylene glycol) thin films.In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin.Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis.Hemocompatibility of styrenic block copolymers for use in prosthetic heart valves.Biomimetic materials for tissue engineering.Measurements of attractive forces between proteins and end-grafted poly(ethylene glycol) chains.Fluorescence correlation spectroscopy of CdSe/ZnS quantum dot optical bioimaging probes with ultra-thin biocompatible coatings.Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization.Polymer-based scaffold designs for in situ vascular tissue engineering: controlling recruitment and differentiation behavior of endothelial colony forming cells.Interferometric silicon biochips for label and label-free DNA and protein microarrays.Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine.Designing Bioinspired Anti-Biofouling Surfaces based on a Superwettability Strategy.Surface Modification of Water Purification Membranes.Functional assay of antiplatelet drugs based on margination of platelets in flowing bloodEvaluation of the role of substrate and albumin on Pseudomonas aeruginosa biofilm morphology through FESEM and FTIR studies on polymeric biomaterials.Effect of hyaluronic acid incorporation method on the stability and biological properties of polyurethane-hyaluronic acid biomaterials.Effect of foreign surface pacification with albumin, aprotinin, propofol, and high-density lipoprotein.Preparation of albumin preferential surfaces on poly(vinyl chloride) membranes via surface self-segregation.Hemocompatibility of Superhemophobic Titania Surfaces.Surface modification of ultrahigh molecular weight polyethylene by the poly(ethylene glycol)-grafted method and its effect on the adsorption of proteins and the adhesion of blood platelets.Modulating the Release Kinetics of Paclitaxel from Membrane-Covered Stents Using Different Loading Strategies.A Dynamically Tunable, Bioinspired Micropatterned Surface Regulates Vascular Endothelial and Smooth Muscle Cells Growth at Vascularization.Synthesis of functionalized, dispersible carbon-coated cobalt nanoparticles for potential biomedical applications.The effect of heparinized decellularized scaffolds on angiogenic capability.The hydration properties of carboxybetaine zwitterion brushes.Drug release from new bioartificial hydrogel.Surface grafting of blood compatible zwitterionic poly(ethylene glycol) on diamond-like carbon-coated stent.Plasma Surface Modification of Biomedical Polymers: Influence on Cell-Material InteractionSurface Initiated Polymerization from Nanoparticle SurfacesModification of Polysiloxane Networks for Biocompatibility
P2860
Q30843340-377E841A-BB3D-4A89-88B9-94C7B4C64053Q31937110-11697169-48D6-4624-A2C0-379E3292964BQ32047950-B3AAAFE6-8986-4E3D-91AC-4651C35733CEQ33271334-B1FB810D-29B1-4EE5-ABB9-49756DBBC70FQ33701714-5D14661A-E414-446E-9A43-DFEE0DD43C78Q33957905-446F6ADE-C0B6-41DE-BC3D-E5ACB5E94DF8Q34192468-929DE46F-E20C-484A-8C73-977A5399A591Q34312430-6C0A3EA7-1AA3-4BD4-ADAB-7E3AF9FE60B8Q34644991-631AD8C7-419C-4C64-9BE6-3C53EBD8F3EBQ35125057-8484C3C2-A5F8-4F32-8988-9F72061921D8Q35167245-B3D10E69-3FCA-4804-B735-8A04944BAC80Q36403365-07D69B12-B411-488A-853F-8423C7E05850Q36502929-851ABE27-0FEE-4F61-BDC5-549F99953708Q36540464-5D5306A1-2FED-40EB-8574-86D3816FA72FQ37246085-1D1291FA-520A-4755-9E32-0BE77F1F492EQ37734500-4947FCCE-28BA-4F7F-9DD5-1A97A7904C8CQ38008288-BF36A65A-9A32-4CBF-A52D-5F76DD9EF16FQ38038828-F01DE215-9507-4FB3-8104-99A82FDED515Q38473677-A2D19B6E-B144-4320-953B-C9D9AFD3C90CQ38903153-B3EC0800-6B47-49BE-B33F-AE0511EBD475Q38948831-C6EA4A60-3AE1-435C-A481-6B5873B73C1FQ39800614-BB5FD8A6-5E30-4364-A590-B56CF92F399EQ40347676-4D270300-C39A-4F9D-811B-EA4D3C3861B2Q42006729-1310AEC2-1501-4AE5-A5C3-FDDA1F1D1A9FQ43128164-7770EF31-91B1-4A50-8AA2-39DF9FDB9623Q43990605-70E4228D-C9E6-4453-BD0C-90D93DC0943EQ45863111-A515B776-F721-4674-B0F3-03192A681681Q47297077-D428CD14-AB18-41FE-A662-C3A58855E961Q49318095-E503271A-ACA9-4D0E-BBC9-B9BBB6CDE760Q50615765-322F4627-91B2-4102-901C-284D11AF2E77Q51033295-CACAFDA9-DB2D-4F57-8A70-BB876CD6390DQ51122138-9C1AFB12-8EE1-428E-BD52-47638C65A469Q51665049-702C7DA6-E7BF-41FB-8AE0-CB66305BAC1FQ52357779-7B957E92-5DE1-4101-B24F-49160FEF5155Q53440350-2CABA48E-77FD-497A-BEAC-D2C9D37F1CFDQ57351357-917B829A-D91A-45A2-A196-2AD3410199DBQ57373277-F1092AEF-7979-4D74-9E12-F35D743F4FAAQ57378426-E86EB18D-5B68-45FE-AC17-4E7C3E6476AD
P2860
Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Surface modification of polyme ...... n for reduced thrombogenicity.
@en
type
label
Surface modification of polyme ...... n for reduced thrombogenicity.
@en
prefLabel
Surface modification of polyme ...... n for reduced thrombogenicity.
@en
P2860
P356
P1476
Surface modification of polyme ...... n for reduced thrombogenicity.
@en
P2860
P304
P356
10.1163/156856293X00537
P577
1993-01-01T00:00:00Z